HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NHS 10-Year Plan A ‘Missed Opportunity’, Says PAGB

Executive Summary

The UK’s consumer healthcare industry association, the Proprietary Association of Great Britain (PAGB), says that National Health Service (NHS) England has “missed an opportunity” by not placing self-care at the center of its new ‘Long Term Plan’.

You may also be interested in...



Reckitt Charges Into UK PPI Heartburn Space With Guardium

With its new esomeprazole-based heartburn and indigestion remedy, Guardium, Reckitt Benckiser is taking head on Pfizer’s well-established Nexium Control brand in the UK. The firm hopes that by associating Guardium with its own well-known heartburn brand Gaviscon, and by investing in a multi-million-pound marketing campaign and pharmacy education, it can carve for itself a significant slice of the UK’s gastrointestinal market.  

Amazon's Alexa To Offer UK Health Advice – But Critics Raise Privacy Fears

The UK government has struck a deal with Amazon to make NHS-verified health advice available to users of the Alexa digital assistant. It says the move will help consumers to self-care with reliable healthcare information. However, detractors have questioned the government's motives and raised data privacy fears.

AESGP Annual Meeting, Day 2: Grappling With Environmental Concerns, 'Nudging' Towards Self-Care Adoption, And Future Trends

A wide range of speakers, such as from GSK and RB, as well as the European Commission, OECD and Deloitte, debated at the AESGP's Annual Meeting in Geneva global self-care policy, how environmental concerns impact industry, ways to ‘nudge’ consumers towards OTCs, and future trends in the market.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148423

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel